Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rang in aandelen #1815
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Aandeelprijs
$334.75
Laatst gesynchroniseerd: 2024-05-30
Marktkapitalisatie
$12.46B
Verandering (1 dag)
-0.02%
Verandering (1 jaar)
0.00%
Land
US
Handel ShockWave Medical, Inc. (SWAV)

Categorie

Winst voor ShockWave Medical, Inc. (SWAV)
Winst in Mar 2024 TTM: $183.54M
Volgens de meest recente financiële verslagen van ShockWave Medical, Inc. bedraagt de huidige winst van het bedrijf $183.54M. In 2022 behaalde het bedrijf een winst van $120.83M, een stijging ten opzichte van de winst van 2021, die $-8.84M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van ShockWave Medical, Inc. van 2017 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $183.54M 5.31%
2023 $174.28M 44.24%
2022 $120.83M -1,467.61%
2021 $-8.84M -86.54%
2020 $-65.62M 28.55%
2019 $-51.05M 24.31%
2018 $-41.06M 34.24%
2017 $-30.59M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.51B 3,992.23%
US
$5.15B 2,704.79%
US
$5.56B 2,930.90%
IE
$3.86B 2,003.59%
US
- -
DE